A Study Tried to Use Genetics to Explain Why People Are Poor
By Dan Samorodnitsky,
VICE
| 01. 24. 2020
It’s tempting to see genes everywhere, lurking in every shadow. For geneticists trying to understand a disease, or Bret Stephens writing an unprompted article about "Jewish genius," genes seem powerful and mysterious, as if they could potentially contain the answer to any of life's questions.
Genetics’ allure can draw people away from more obvious explanations for problems. Here’s a hypothetical. Imagine a poor neighborhood on the side of a highway. If you notice that people living in poor neighborhoods next to highways get asthma more often than rich people across town, you could study their genomes and find some genes common in poor asthmatics. Some of those might even be for genes expressed in the throat and lungs, and then suddenly it seems like poor people are genetically predisposed to having asthma, all while ignoring the much simpler explanation that poor people are breathing in car exhaust while rich people aren’t.
Viewing genes as a determining factor while ignoring larger systemic and societal issues is misleading. For example, scientists recently went looking for a link between individual variations in people’s...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...